HomeLPCN • NASDAQ
add
Lipocine Inc
Previous close
$3.50
Day range
$3.16 - $3.60
Year range
$2.91 - $11.79
Market cap
18.93M USD
Avg Volume
20.75K
P/E ratio
2,298.70
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.49M | 1,514.99% |
Operating expense | 1.95M | -30.74% |
Net income | 1.78M | 178.09% |
Net profit margin | 51.04 | 104.83% |
Earnings per share | — | — |
EBITDA | 1.55M | 160.11% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.63M | -1.83% |
Total assets | 22.51M | -2.13% |
Total liabilities | 1.51M | -42.51% |
Total equity | 21.00M | — |
Shares outstanding | 5.35M | — |
Price to book | 0.89 | — |
Return on assets | 17.88% | — |
Return on capital | 19.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.78M | 178.09% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1997
Headquarters
Website
Employees
16
